JPML Consolidates Effexor Birth Defect Actions In Pa.

Law360, New York (August 7, 2013, 1:49 PM EDT) -- The U.S. Judicial Panel on Multidistrict Litigation on Tuesday grouped nine product liability suits in Pennsylvania alleging Wyeth Pharmaceuticals Inc.'s depression and anxiety drug Effexor caused birth defects in children whose mothers used it during pregnancy.

The panel assigned the litigation to U.S. District Judge Cynthia M. Rufe in the Eastern District of Pennsylvania, saying she is best suited to hear the case since she already is overseeing multidistrict litigation with parallel claims involving Wyeth and its parent Pfizer Inc. over antidepressant Zoloft’s alleged links to...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

IN RE: EFFEXOR (VENLAFAXINE HYDROCHLORIDE) PRODUCTS LIABILITY LITIGATION


Case Number

2:13-md-02458

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Personal Inj. Prod. Liability

Judge

CYNTHIA M. RUFE

Date Filed

August 6, 2013

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.